24-Apr-2024
No headlines found.
No press releases found.
No news found.
The Invesco Dynamic Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Invesco Dynamic Biotechnology & Genome ETF trades on the ARCA stock market under the symbol PBE.
As of April 24, 2024, PBE stock price declined to $60.88 with 5,325 million shares trading.
PBE has a market cap of $230.74 million. This is considered a Small Cap stock.
In the last 3 years, PBE stock traded as high as $79.92 and as low as $51.39.
PBE has underperformed the market in the last year with a price return of -3.3% while the SPY ETF gained +24.1%. PBE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.1% and -2.8%, respectively, while the SPY returned +4.5% and -1.7%, respectively.
PBE support price is $60.39 and resistance is $61.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PBE stock will trade within this expected range on the day.